Janssen Robert 4
4 · DYNAVAX TECHNOLOGIES CORP · Filed Feb 13, 2024
Insider Transaction Report
Form 4
Janssen Robert
Chief Medical Officer and VP
Transactions
- Exercise/Conversion
Restricted Stock Unit
2024-02-10−4,333→ 4,333 total→ Common Stock (4,333 underlying) - Exercise/Conversion
Common Stock
2024-02-10+4,333→ 60,215 total - Tax Payment
Common Stock
2024-02-12$12.82/sh−1,531$19,627→ 58,684 total
Footnotes (4)
- [F1]Code M: Exercise or conversion of derivative security
- [F2]Each RSU represents a contingent right to receive one share of common stock. The RSUs vest over three years with 1/3 vesting on each annual anniversary of February 10, 2022.
- [F3]Code F: Payment of exercise price or tax liability by delivering or withholding securities
- [F4]Shares withheld by Dynavax Technologies Corporation to satisfy tax withholding requirements on vesting of restricted stock units.